Patrick Lu, Sirnaomics CEO
Low-profile RNAi player lands on HKEX following modest $50M IPO
A low-profile small interfering RNA player has managed to squeeze in its IPO before the year ends, adding another listing to the Hong Kong stock …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
